DUBOVSKY; Jason A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for DUBOVSKY; Jason A..The latest application filed is for "methods for dosing and treatment of b cell malignancies in adoptive cell therapy".

Company Profile

4.5.11

DUBOVSKY; Jason A. - Seattle WA
Dubovsky; Jason A. - Columbus OH
Dubovsky; Jason A. - Tampa FL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods For Dosing And Treatment Of B Cell Malignancies In Adoptive Cell Therapy App 20220031746 - GILLENWATER; Heidi ; et al.	2022-02-03
Methods Of Treating And Preventing Graft Versus Host Disease App 20210121463 - Byrd; John C. ; et al.	2021-04-29
Combination Therapy Of A Chimeric Antigen Receptor (car) T Cell Therapy And A Kinase Inhibitor App 20210121466 - FRANKEL; Stanley R. ; et al.	2021-04-29
Methods of treating and preventing graft versus host disease Grant 10,695,350 - Byrd , et al.	2020-06-30
Tec Family Kinase Inhibitor Adjuvant Therapy App 20200147084 - Buggy; Joseph J. ; et al.	2020-05-14
Methods Of Treating And Preventing Graft Versus Host Disease App 20200009148 - Byrd; John C. ; et al.	2020-01-09
Methods of treating and preventing graft versus host disease Grant 10,463,668 - Byrd , et al. No	2019-11-05
Methods Of Treating And Preventing Graft Versus Host Disease App 20180078555 - Byrd; John C. ; et al.	2018-03-22
Tec Family Kinase Inhibitor Adjuvant Therapy App 20180071293 - Buggy; Joseph J. ; et al.	2018-03-15
Methods of treating and preventing graft versus host disease Grant 9,795,604 - Byrd , et al. October 24, 2	2017-10-24
TEC family kinase inhibitor adjuvant therapy Grant 9,717,731 - Buggy , et al. August 1, 2	2017-08-01
Methods Of Treating And Preventing Graft Versus Host Disease App 20150118209 - BYRD; John C. ; et al.	2015-04-30
Tec Family Kinase Inhibitor Adjuvant Therapy App 20140371241 - BUGGY; Joseph J. ; et al.	2014-12-18
Prostate Cancer And Melanoma Antigens App 20100124755 - McNeel; Douglas G. ; et al.	2010-05-20
Prostate cancer and melanoma antigens Grant 7,635,753 - McNeel , et al. December 22, 2	2009-12-22
Prostate Cancer And Melanoma Antigens App 20080206289 - McNeel; Douglas G. ; et al.	2008-08-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.